Dr Reddys Laboratories (RDY) Treasury Shares (2019 - 2026)

Dr Reddys Laboratories (RDY) has reported Treasury Shares for 8 consecutive years, with $19.0 million the latest figure, recorded in Q1 2026.

• Quarterly Treasury Shares fell 29.63% year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (down 29.63% YoY) and the FY2026 annual result came in at $19.0 million, down 29.63% from the prior year.
• Treasury Shares declined to $19.0 million in Q1 2026 per RDY's latest filing, from $27.0 million in the prior quarter.
• Over the last five years, Treasury Shares for RDY reached as high as $27.0 million in Q1 2025 and fell as low as $12.0 million in Q1 2024.
• A 5-year average of $18.8 million and a median of $19.0 million in 2026 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2025 — Treasury Shares jumped 125.0% — and 2026, when it declined 29.63%.
• Year by year, Treasury Shares stood at $21.0 million in 2022, then dropped by 28.57% to $15.0 million in 2023, then fell by 20.0% to $12.0 million in 2024, then soared by 125.0% to $27.0 million in 2025, then dropped by 29.63% to $19.0 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $19.0 million, $27.0 million, and $12.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.